EUROPA - Research Information Centre This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Limitare l'impatto di una pratica clinica diffusa, ma potenzialmente dannosa
La profilassi antimicrobica intrapartum (IAP), è una procedura standard per il parto. Secondo ricerche finanziate dall’UE, potrebbe avere rilevanti implicazioni per la salute infantile, aumentando il rischio di obesità, diabete e antibiotico-resistenza. Tale scoperta apre allo sviluppo di nuove strategie dietetiche che limitino gli effetti di questa procedura medica estremamente diffusa. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 9, 2021 Category: Research Source Type: news

Ograniczanie skutków powszechnej, ale potencjalnie szkodliwej, praktyki klinicznej
Śródporodowa profilaktyka zakażeń to standardowa procedura przeprowadzana podczas porodu. Badania finansowanej przez UE badaczki wykazały, że może mieć ona poważne konsekwencje dla zdrowia noworodków, zwiększając ryzyko antybiotykooporności, otyłości i cukrzycy. Ustalenia te wytyczają kierunek nowych strategii żywieniowych mających na celu ograniczenie skutków ubocznych tej powszechnej procedury. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 9, 2021 Category: Research Source Type: news

Particle physicist turns his hand to medical imaging
Technology developed in an EU-funded project for high-energy physics experiments also has the potential to greatly enhance the sensitivity of PET scanners for medical imaging. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 8, 2021 Category: Research Source Type: news

Nanoträger als sicherere Methode der Brustkrebsbehandlung
Betroffene, die sich einer Chemotherapie unterzogen haben, wissen, dass diese trotz ihrer Wirksamkeit auch eine Menge an gesunden Zellen schädigt. Das EU-finanzierte Projekt NANOCARGO hat eine Lösung für Brustkrebs vorangetrieben, die solche Schäden vermeiden würde. Dieser Durchbruch könnte den vielen Frauen in Europa zugutekommen, die sich jedes Jahr gegen Brustkrebs behandeln lassen. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Nanocarriers for safer breast cancer treatment
Patients who've gone through chemotherapy know that as effective as it may be, it also causes a lot of damage to otherwise healthy cells. The EU-funded NANOCARGO project has pushed a solution forward for breast cancer that would avoid such damage. This breakthrough could benefit the many thousands upon thousands of women in Europe who undergo treatment for breast cancer every year. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Unos nanoportadores para un tratamiento más seguro del cáncer de mama
Las personas que pasan por la quimioterapia saben que, por muy eficaz que sea, también causa gran daño a las células sanas. El proyecto financiado con fondos europeos NANOCARGO ha impulsado una solución para el cáncer de mama que evitaría estos daños. Este avance podría beneficiar a las miles y miles de europeas que se someten cada año a un tratamiento contra el cáncer de mama. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Des nanotransporteurs pour un traitement plus sûr du cancer du sein
Les patients qui ont subi une chimiothérapie savent que, malgré son efficacité, elle endommage aussi beaucoup les cellules saines. Le projet NANOCARGO, financé par l’UE, a trouvé une solution qui éviterait ce type de problème pour le cancer du sein. Cette avancée pourrait profiter aux milliers de femmes qui suivent chaque année un traitement contre ce cancer en Europe. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Nanovettori per un trattamento più sicuro del cancro al seno
I pazienti sottoposti a chemioterapia sanno che, per quanto efficace, questa procedura danneggia gravemente anche cellule altrimenti sane. Il progetto NANOCARGO, finanziato dall’UE, ha presentato una soluzione per il cancro al seno che eviterebbe tali danni. La scoperta rivoluzionaria potrebbe aiutare le migliaia di donne in Europa che ogni anno affrontano un trattamento contro il cancro al seno. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Nanonośniki podstawą bezpiecznego leczenia raka piersi
Pacjenci po chemioterapii zdają sobie sprawę, że pomimo swojej skuteczności ta metoda leczenia wiąże się ze zniszczeniem części zdrowych komórek. Finansowany przez UE projekt NANOCARGO opracował nowy lek na raka piersi, który pozwoli uniknąć nadmiernych zniszczeń, co może przynieść korzyści wielu tysiącom Europejek, które każdego roku walczą z nowotworami piersi. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 3, 2021 Category: Research Source Type: news

Pioneering photolithography for 7nm chips
Cutting-edge photolithography technology developed by an EU-funded consortium has enabled the launch of a new generation of high-performance smartphones featuring powerful and efficient 7nm-node mobile processors. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 2, 2021 Category: Research Source Type: news

Solving shared problems in environmental research
For years, environmental scientists across different disciplines have struggled with the same technical challenges. In response, EU-funded researchers have created a community where scientists can pool their resources to find joint solutions to common problems. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 1, 2021 Category: Research Source Type: news

En route to safer, more reliable autonomous driving
The development of autonomous driving systems is currently a focus of research for the automotive industry. An EU-funded project has moved work forward in this area by developing an advanced driver-assistance system that can work safely and reliably in all weathers. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 27, 2021 Category: Research Source Type: news

Neue Technik hilft, das Risiko der Entwicklung altersbedingter Augenerkrankungen zu mindern
Mit steigender Lebenserwartung riskieren immer mehr Menschen, altersbedingte Augenerkrankungen zu entwickeln, die zur Erblindung führen können. Zur Behandlung und Versorgung der Erkrankten müssen die Risikofaktoren verstanden werden. Ein EU-finanziertes Projekt entwickelte neue Instrumente zur Vorhersage der Wahrscheinlichkeit, eine Augenkrankheit zu entwickeln, sowie Schritte zur Risikominderung. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 26, 2021 Category: Research Source Type: news

New techniques help decrease the risk of developing age-related eye disease
With life expectancy on the rise, more and more people are at risk of developing age-related eye diseases that could cause blindness. The key to treating and managing such diseases is to understand the risk factors involved. To help, one EU-funded project has developed tools that predict not only how likely a person is to develop eye diseases but also what can be done to lower this risk. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 26, 2021 Category: Research Source Type: news

Nuevas técnicas reducen el riesgo de enfermedades oculares asociadas a la edad
Con la esperanza de vida en alza, cada vez más gente corre el riesgo de desarrollar enfermedades oculares asociadas a la edad que causarían ceguera. La clave para tratarlas y controlarlas es entender los factores de riesgo. Un proyecto financiado con fondos europeos desarrolló herramientas que pueden predecir la probabilidad de desarrollar enfermedades oculares y qué hacer para reducir este riesgo. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 26, 2021 Category: Research Source Type: news